Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2014

01-04-2014 | Review Article

History of Kawasaki disease

Authors: Tomisaku Kawasaki, Shiro Naoe

Published in: Clinical and Experimental Nephrology | Issue 2/2014

Login to get access

Abstract

We describe a short history of Kawasaki disease. In 1967, we published a paper entitled ‘Infantile acute febrile mucocutaneous lymph node syndrome with specific desquamation of the fingers and toes. Clinical observation of 50 cases’; this was the first report on what is now called Kawasaki disease. Since then, many reports on cardiology, treatment, epidemiology, pathology and etiology of Kawasaki disease have been published. Furthermore, a recent Chapel Hill Consensus Statement on Kawasaki disease in the classification of vasculitis is given, along with a figure on the relationship and classification of childhood vasculitis by autopsy material.
Literature
1.
go back to reference Kawasaki T. Infantile acute febrile mucocutaneous lymph node syndrome with specific desquamation of the fingers and toes. Clinical observation of 50 cases. Jpn J Allerg. 1967;178–222 (in Japanese with English abstract). Kawasaki T. Infantile acute febrile mucocutaneous lymph node syndrome with specific desquamation of the fingers and toes. Clinical observation of 50 cases. Jpn J Allerg. 1967;178–222 (in Japanese with English abstract).
2.
go back to reference Kato H, et al. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892–8.PubMedCrossRef Kato H, et al. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892–8.PubMedCrossRef
3.
go back to reference Nakano H, et al. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol. 1983;56:846–51.CrossRef Nakano H, et al. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol. 1983;56:846–51.CrossRef
4.
go back to reference Furusho K, et al. High-dose intravenous gamma globulin for Kawasaki disease. Lancet 1984;1055–1058. Furusho K, et al. High-dose intravenous gamma globulin for Kawasaki disease. Lancet 1984;1055–1058.
5.
go back to reference Burns JC, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005;146:662–7.PubMedCrossRef Burns JC, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005;146:662–7.PubMedCrossRef
6.
go back to reference Nakamura Y, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010, nationwide survey. J Epidemiol. 2012;22:216–21.PubMedCentralPubMed Nakamura Y, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010, nationwide survey. J Epidemiol. 2012;22:216–21.PubMedCentralPubMed
Metadata
Title
History of Kawasaki disease
Authors
Tomisaku Kawasaki
Shiro Naoe
Publication date
01-04-2014
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2014
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0877-6

Other articles of this Issue 2/2014

Clinical and Experimental Nephrology 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.